RESUMO
OBJECTIVES: To investigate the effects of LL-37, a broad spectrum antimicrobial peptide expressed in periodontal tissues, on human gingival fibroblast responsiveness to microbial challenge and to explore the direct effects of LL-37 on human gingival fibroblasts. DESIGN: The effect of LL-37 on bacterial lipopolysaccharide-induced expression of Interleukin (IL-6) and chemokine C-X-C motif ligand (CXCL) 8 was determined by enzyme linked immunosorbent assay (ELISA). LL-37's influence on bacterial lipopolysaccharide-induced IκBα degradation was investigated by western blot. DNA microarray analysis initially determined the direct effects of LL-37 on gene expression, these findings were subsequently confirmed by quantitative polymerase chain reaction and ELISA analysis of selected genes. RESULTS: Bacterial lipopolysaccharide-induced IL-6 and CXCL8 production by human gingival fibroblasts was significantly reduced in the presence of LL-37 at concentrations in the range of 1-10 µg/ml. LL-37 led to a reduction in lipopolysaccharide-induced IκBα degradation by Escherichia coli lipopolysaccharide and Porphyromonas gingivalis lipopolysaccharide (10 µg/ml). LL-37 (50 µg/ml) significantly altered the gene expression of 367 genes in human gingival fibroblasts by at least 2-fold. CXCL1, CXCL2, CXCL3, Interleukin-24 (IL-24), CXCL8, Chemokine (C-C motif) Ligand 2, and Suppressor of Cytokine Signalling 3 mRNA were significantly upregulated by LL-37. LL-37 also significantly stimulated expression of CXCL8, hepatocyte growth factor and CXCL1 at the protein level. CONCLUSION: LL-37 plays an important regulatory role in the immunomodulatory activity of gingival fibroblasts by inhibiting lipopolysaccharide -induced expression of inflammatory cytokines and directly stimulating the expression of an array of bioactive molecules involved in inflammation and repair.
Assuntos
Catelicidinas , Lipopolissacarídeos , Humanos , Catelicidinas/metabolismo , Catelicidinas/farmacologia , Inibidor de NF-kappaB alfa/metabolismo , Inibidor de NF-kappaB alfa/farmacologia , Lipopolissacarídeos/farmacologia , Interleucina-6/metabolismo , Peptídeos Antimicrobianos , Gengiva/metabolismo , Citocinas/metabolismo , Porphyromonas gingivalis/metabolismo , Quimiocinas/metabolismo , Fibroblastos , Células CultivadasRESUMO
AIM: To investigate the ability of dead odontoblasts to initiate NLRP3 inflammasome-dependent sterile inflammation and to explore the effect on dental pulp cell (DPCs) migration, proliferation and odontogenic differentiation. METHODS: Odontoblast-like cells were subjected to freezing-thawing cycles to produce odontoblast necrotic cell lysate (ONCL). DPCs were treated with ONCL to assess proliferation and migration. THP-1 differentiated macrophages stimulated with ONCL and live cell imaging and western blotting were used to assess NLRP3 inflammasome activation. Cytokines were measured with multiplex arrays and ELISA. qPCR, alkaline phosphatase and Alizarin red assays were used to assess odontogenic differentiation of DPCs. Data were analysed using the t-test or anova followed by a Bonferroni post hoc test with the level of significance set at P ≤ 0.05. RESULTS: ONCL induced migration and proliferation of DPCs. Treatment of THP-1 macrophages with ONCL resulted in the release of the inflammatory cytokines IL-1ß, IL-6, IL-8, TNFα, IFN-γ, CCL2 and angiogenic growth factors, angiogenin and angiopoietin. This inflammatory response was associated with activation of NFκB, p38MAPK and NLRP3 inflammasome. To confirm that ONCL induced inflammatory response is NLRP3 inflammasome-dependent, treatment with a caspase-1 inhibitor and a specific NLRP3 inhibitor significantly reduced IL-1ß release in THP-1 macrophages (P = 0.01 and 0.001). Inflammasome activation product, IL-1ß, induced odontogenic differentiation of DPCS as evident by the increase in odontogenic genes expression DMP-1, RUNX-2, DSPP and SPP, alkaline phosphatase activity and mineralization. CONCLUSION: Dead odontoblasts induced NLRP3 inflammasome-dependent sterile inflammation and activated the migration, proliferation and differentiation of DPCs.
Assuntos
Inflamassomos , Odontoblastos , Morte Celular , Diferenciação Celular , Movimento Celular , Proliferação de Células , Polpa Dentária , Humanos , Inflamação , Interleucina-1beta , Proteína 3 que Contém Domínio de Pirina da Família NLRRESUMO
BACKGROUND AND OBJECTIVE: The matrix metalloproteinases (MMPs) play a role in regulating turnover and metabolism of connective tissues in health but they have also been implicated in a wide variety of pathological conditions, including periodontal disease. MMP-8 has been extensively studied in periodontal health and disease using ELISA, although this technique is limited by its inability to determine enzyme activity. The aim was to develop an assay specifically to measure MMP-8 activity and to demonstrate its use in the analysis of gingival crevicular fluid samples. MATERIAL AND METHODS: A specific antibody was used to coat black 96-well microtitre plates to capture MMP-8 selectively. The activity of bound MMP-8 was measured using a fluorogenic substrate. Gingival crevicular fluid samples, from healthy and periodontally diseased sites, were collected using PerioPaper strips and tested for MMP-8 activity. RESULTS: Significantly higher MMP-8 activity was demonstrated in gingival crevicular fluid from periodontally diseased sites compared with healthy sites that exhibited basal or no MMP-8 activity. No cross-reactivity with other MMPs was noted. CONCLUSION: We show, for the first time, that MMP-8 activity can be specifically detected and quantified in gingival crevicular fluid samples. Measurement of MMP-8 activity could prove to be useful in monitoring periodontal disease progression.
Assuntos
Ensaio de Imunoadsorção Enzimática/métodos , Líquido do Sulco Gengival/enzimologia , Metaloproteinase 8 da Matriz/metabolismo , Adulto , Idoso , Anticorpos/imunologia , Periodontite Crônica/enzimologia , Humanos , Metaloproteinase 8 da Matriz/imunologia , Pessoa de Meia-IdadeRESUMO
OBJECTIVE: To investigate the potential effects of IFN-03A5 on the responsiveness of human gingival fibroblasts to bacterial challenge. DESIGN: mRNA and protein expression of CD14, TLR2 and TLR4 in human gingival fibroblasts was detected by quantitative polymerase chain reaction (Q-PCR) and flow cytometry. The effect of preincubation with IFN-03A5 on subsequent bacterial LPS-induced expression of IL-6 and IL-8 by gingival fibroblasts was determined by ELISA. Bacterial LPS-induced IκBα degradation in human gingival fibroblasts was investigated by western blot. RESULTS: Human gingival fibroblasts express CD14, TLR2 and TLR4 mRNAs. IFN-03A5, but not IL-103B2, induced mRNA expression of all three receptors and the expression of membrane bound CD14 protein. Pre-incubation of fibroblasts with IFN-03A5 and subsequent stimulation with Escherichia coli LPS or Porphyromonas gingivalis LPS led to increased production of IL-6 and IL-8. LPS-induced pro-inflammatory cytokine production was abrogated by a blocking antibody to CD14. Both E. coli LPS and P. gingivalis LPS induced IκBα degradation in human gingival fibroblasts. CONCLUSION: Our data indicate that IFN-03A5 primes human gingival fibroblasts, through the upregulation of CD14 expression, which results in increased responsiveness to bacterial LPS challenge, as determined by pro-inflammatory cytokine production.
Assuntos
Fibroblastos/efeitos dos fármacos , Gengiva/citologia , Interferon gama/farmacologia , Receptores de Lipopolissacarídeos/metabolismo , Lipopolissacarídeos/farmacologia , RNA Mensageiro/metabolismo , Receptor 2 Toll-Like/metabolismo , Receptor 4 Toll-Like/metabolismo , Western Blotting , Células Cultivadas , Ensaio de Imunoadsorção Enzimática , Escherichia coli/imunologia , Citometria de Fluxo , Humanos , Reação em Cadeia da Polimerase , Regulação para CimaRESUMO
AIM: The aim of the study was to evaluate the effect of topical phenytoin on healing in diabetic foot ulcers. A randomized, controlled, double-blind, clinical trial was conducted. METHODS: A phenytoin dressing and a control dressing were manufactured. Individuals who were ≥ 18 years of age with peripheral neuropathy, an ankle brachial pressure index > 0.5 and a diabetic foot ulcer ≥ 4 weeks' duration were independently randomized to the phenytoin group (31 participants) or the control group (34 participants). Participants with renal disease, ankle brachial pressure index < 0.5, necrosis or osteomyelitis were excluded. Subjects received standard wound care and dressing application. Primary endpoint analysis (diabetic foot ulcer closed or not at 16 weeks) was calculated by survival analysis. RESULTS: Participants (n = 65, 52 with Type 2 diabetes) were treated for a maximum of 16 weeks. Sixty per cent of the diabetic foot ulcers closed overall (18 in the phenytoin group, 20 in the control group) with no statistically significant differences in complete healing or in diabetic foot ulcer area over time between the two groups. At 24-weeks follow-up, one diabetic foot ulcer had recurred. CONCLUSIONS: There were no differences in diabetic foot ulcer closure rates or in diabetic foot ulcer area over time between the two groups. This study does not support the use of phenytoin in the treatment of diabetic foot ulcers.
Assuntos
Fármacos Dermatológicos/farmacologia , Pé Diabético/tratamento farmacológico , Fenitoína/farmacologia , Cicatrização/efeitos dos fármacos , Administração Cutânea , Índice de Massa Corporal , Fármacos Dermatológicos/administração & dosagem , Diabetes Mellitus Tipo 1/complicações , Diabetes Mellitus Tipo 1/fisiopatologia , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/fisiopatologia , Angiopatias Diabéticas/complicações , Angiopatias Diabéticas/fisiopatologia , Pé Diabético/fisiopatologia , Método Duplo-Cego , Feminino , Hemoglobinas Glicadas/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade , Fenitoína/administração & dosagem , Falha de TratamentoRESUMO
AIM: To investigate whether dental pulp fibroblasts express neuropeptide Y (NPY) and NPY-Y1 in vitro and to determine the effects of the cytokines including interleukin-1ß (IL-1ß), TGF- ß(1) , substance P and NPY on the expression of NPY Y1. METHODOLOGY: Three primary fibroblast cell strains were obtained from freshly extracted human third molar teeth. RT-PCR was utilized to detect expression of NPY and mRNA expression. Membrane protein samples were isolated, and protein expression was determined by Western blotting. Radioimmunoassay was used to quantify NPY expression in healthy (n = 35) and carious (n = 39) whole pulp samples, and the student's t-test was used to test for statistical significance. In addition, the 3-(4,5-Dimethylthiazol,2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to assay fibroblast cell growth. RESULTS: mRNA transcripts were found in all three fibroblast cell populations with the cytokines having a stimulatory effect on its expression (P < 0.05). NPY mRNA was not detected in the cell strains. NPY-Y1 receptor protein expression was visualized by Western blotting, and there was no effect of IL-1ß or TGF- ß(1) on its expression. The mean concentration of NPY-Ir determined by radioimmunoassay in non-carious teeth was 19.40 ng x g(-1) (±17.03 SD) compared to 29.95 ng x g(-1) (±20.99 SD) in carious teeth (P < 0.05). CONCLUSION: Human dental pulp fibroblasts express, but do not synthesize, NPY, demonstrating that the fibroblast is a target cell for NPY. The effect of proinflammatory cytokines suggests that fibroblasts play a neuroimmunomodulatory role in the pulpal response to dental caries and injury.
Assuntos
Polpa Dentária/metabolismo , Fibroblastos/metabolismo , Neuropeptídeo Y/análise , Receptores de Neuropeptídeo Y/análise , Western Blotting , Técnicas de Cultura de Células , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Corantes , Cárie Dentária/metabolismo , Polpa Dentária/citologia , Polpa Dentária/efeitos dos fármacos , Fibroblastos/efeitos dos fármacos , Humanos , Interleucina-1beta/farmacologia , Proteínas de Membrana/análise , Neuroimunomodulação , Neuropeptídeo Y/farmacologia , Receptores de Neuropeptídeo Y/efeitos dos fármacos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Substância P/farmacologia , Sais de Tetrazólio , Tiazóis , Fator de Crescimento Transformador beta/farmacologiaRESUMO
Protease-activated receptors (PARs) are G-protein-coupled receptors that are activated enzymatically by proteolysis of an N-terminal domain. The cleavage and activation of PARs by serine proteases represent a novel mechanism by which such enzymes could influence the host inflammatory response. The aim of this study was to determine whether PAR-2 expression and activation were increased in dental caries. Using immunohistochemistry, we showed PAR-2 to be localized to pulp cells subjacent to caries lesions, but minimally expressed by healthy pulp tissue. Trypsin and the PAR-2 agonist (PAR2-AP) activated PAR-2 in an in vitro functional assay. Endogenous molecules present in pulp cell lysates from carious teeth specifically activated PAR-2, but those from healthy teeth failed to do so. The activation of PAR-2 in vitro was shown to increase the expression of the pro-inflammatory mediator cyclo-oxygenase-2 (COX-2), providing a mechanism whereby PAR-2 could modulate pulpal inflammation.
Assuntos
Cárie Dentária/metabolismo , Pulpite/metabolismo , Receptor PAR-2/análise , Western Blotting , Cálcio/análise , Células Cultivadas , Ciclo-Oxigenase 2/análise , Cárie Dentária/patologia , Eletroforese em Gel de Poliacrilamida , Ativação Enzimática , Fibroblastos/metabolismo , Fibroblastos/patologia , Humanos , Imuno-Histoquímica , Mediadores da Inflamação/análise , Pulpite/patologia , Receptor PAR-2/agonistas , Tripsina/farmacologiaRESUMO
BACKGROUND AND OBJECTIVE: The unusual structure and functions of junctional epithelium, together with its pattern of migration in periodontal disease, raise interesting questions about the factors associated with the maintenance of its unique phenotype. To explore the effects of regionally differing fibroblast populations on the growth and patterns of differentiation of oral epithelia, this study used an organotypical in vitro model in an attempt to detect interactions occurring between populations of human oral fibroblasts and keratinocytes. MATERIAL AND METHODS: Keratinocytes and fibroblasts, isolated from the gingival region and periodontal ligament, were characterized by their patterns of growth and by their expression of known differentiation markers. Changes in cell behaviour and phenotypic marker expression were examined during in vitro passage as an indication of the maintenance of in vivo phenotypic traits. Using early passage cells, organotypical cultures were generated and patterns of epithelial growth and expression of phenotypic markers were examined. RESULTS: Phenotypically different populations of junctional and oral-gingival keratinocytes, and of oral-gingival and periodontal ligament fibroblasts, were successfully isolated, cultured and characterized. In the organotypic culture system, oral-gingival fibroblasts were found to have a markedly greater ability than periodontal ligament fibroblasts to support and maintain the growth of either type of epithelium. Shifts of epithelial phenotype were induced by different fibroblasts. CONCLUSION: Periodontal and gingival fibroblast subpopulations have differential effects on the growth and patterns of differentiation of oral and junctional epithelia. By modulating the epithelial phenotype, regionally differing fibroblasts can influence the stability and behaviour of the gingival attachment apparatus in health and disease.
Assuntos
Inserção Epitelial/fisiologia , Gengiva/fisiologia , Ligamento Periodontal/fisiologia , Adolescente , Adulto , Fosfatase Alcalina/metabolismo , Comunicação Celular , Diferenciação Celular , Proliferação de Células , Células Cultivadas , Desmoplaquinas/biossíntese , Inserção Epitelial/citologia , Fibroblastos/metabolismo , Fibroblastos/fisiologia , Gengiva/citologia , Humanos , Molécula 1 de Adesão Intercelular/biossíntese , Queratinócitos/metabolismo , Queratinócitos/fisiologia , Queratinas/biossíntese , Técnicas de Cultura de Órgãos , Ligamento Periodontal/citologia , Fenótipo , Receptores Mitogênicos/metabolismoRESUMO
While skin wounds heal by scarring, wounds of oral mucosa show privileged healing with minimal scar formation. Our hypothesis was that phenotypic differences between oral and skin fibroblasts underlie these differences in healing. The aims of this study were to compare MMP-3 expression by oral and skin fibroblasts and investigate a role for MMP-3 in mediating collagen gel contraction. Oral fibroblasts induced significantly greater gel contraction than did paired skin cells. Inhibition of MMP activity significantly inhibited gel contraction by both cell types. Specific inhibition of MMP-3 activity reduced gel contraction by oral, but not skin, fibroblasts. Oral fibroblasts produced significantly higher levels of MMP-3 than did skin fibroblasts at all levels studied. TGF-beta1 and -beta3 isoforms stimulated MMP-3 expression at mRNA, protein, and activity levels by both fibroblast populations. Results suggest that increased MMP-3 production by oral fibroblasts may underlie the differences in wound-healing outcome seen in skin and oral mucosa.
Assuntos
Metaloproteinase 3 da Matriz/fisiologia , Mucosa Bucal/enzimologia , Pele/enzimologia , Cicatrização/fisiologia , Actinas/biossíntese , Adulto , Células Cultivadas , Colágeno Tipo I/fisiologia , Fibroblastos/enzimologia , Humanos , Metaloproteinase 3 da Matriz/biossíntese , Inibidores de Metaloproteinases de Matriz , Mucosa Bucal/citologia , Mucosa Bucal/fisiologia , Isoformas de Proteínas , Pele/citologia , Fenômenos Fisiológicos da Pele , Fator de Crescimento Transformador beta/química , Fator de Crescimento Transformador beta/fisiologiaRESUMO
BACKGROUND: Epithelial proliferation is a histological characteristic of drug-induced gingival overgrowth. Keratinocyte growth factor (KGF) and scatter factor (SF) are fibroblast-derived growth factors with potent mitogenic and motogenic effects on epithelial cells, and, therefore, could be involved in the pathogenesis of gingival overgrowth. The aims of this study were to investigate: (i) the effects of cyclosporin on KGF and SF expression by gingival fibroblasts; and (ii) the expression levels of KGF and SF mRNA in normal and overgrown gingival tissue. METHODS: The KGF and SF protein production was determined by enzyme-linked immunosorbent assay. Relative levels of KGF and SF mRNA expression were determined using semi-quantitative reverse transcriptase polymerase chain reaction. Expression levels in biopsies of normal and overgrown gum were also determined. RESULTS: In overgrown fibroblasts, 500 ng/ml cyclosporin significantly inhibited KGF and SF mRNA and protein while 2000 ng/ml cyclosporin induced a stimulatory effect. In normal cells cyclosporin significantly increased both KGF and SF. KGF and SF mRNA was detected in both normal and overgrown tissues with a tendency towards increased expression levels in overgrown tissue. CONCLUSION: These results suggest that KGF and SF may have an important role in cyclosporin-induced gingival overgrowth.
Assuntos
Ciclosporina/farmacologia , Fatores de Crescimento de Fibroblastos/biossíntese , Crescimento Excessivo da Gengiva/induzido quimicamente , Crescimento Excessivo da Gengiva/metabolismo , Fator de Crescimento de Hepatócito/biossíntese , Imunossupressores/farmacologia , Adulto , Análise de Variância , Células Cultivadas , Ensaio de Imunoadsorção Enzimática , Células Epiteliais/efeitos dos fármacos , Fator 7 de Crescimento de Fibroblastos , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Expressão Gênica/efeitos dos fármacos , Gengiva/efeitos dos fármacos , Gengiva/metabolismo , Humanos , Masculino , RNA Mensageiro/biossíntese , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Estatísticas não ParamétricasRESUMO
BACKGROUND: Skin and oral mucosal keratinocytes grown in vitro usually lose their normal patterns of differentiation, unless grown as organotypical cultures that are constructed by allowing collagen gels containing fibroblasts to contract before they are plated with keratinocytes and raised to the air/medium interface. However, the contraction process tends to produce small irregular cultures. METHODS: To generate uniformly differentiating large cultures, we have investigated several aspects of the factors involved in the culture construction. By adjusting the number of fibroblasts used and by plating the matrices with keratinocytes prior to contraction, cultures of up to 72 cm2 were constructed. RESULTS: The cultures retained almost the full surface areas of the original matrices and showed uniform patterns of epithelial plating and differentiation. Immunostaining for cytokeratins and integrins indicated restoration of in vitro phenotypes similar to those of the epithelial tissues of origin. CONCLUSIONS: These methods successfully generate cultures required for certain types of investigations and tissues that are suitable for clinical use as grafts.
Assuntos
Técnicas de Cultura , Queratinócitos/citologia , Mucosa Bucal/citologia , Pele/citologia , Adulto , Animais , Diferenciação Celular , Divisão Celular , Colágeno , Meios de Cultura , Cães , Células Epiteliais/citologia , Fibroblastos/citologia , Géis , Humanos , Integrinas/análise , Queratinas/análise , FenótipoRESUMO
BACKGROUND: The purpose of this study was to determine whether the prevalence and severity of gingival overgrowth in renal transplant recipients concomitantly treated with cyclosporin and a calcium channel blocker was associated with functional polymorphisms within the signal sequence of the transforming growth factor-(TGF)beta1 gene. METHODS: The extent and severity of gingival overgrowth for 164 renal transplant recipients immunosuppressed with cyclosporin A and concomitantly taking a calcium channel blocker since transplant were entered into the study (86 in Manchester, 78 in Belfast). Two biallelic polymorphisms of the TGF-beta1 gene were studied at position +869, codon 10 (leucine to proline substitution), and position +915, codon 25 (arginine to proline substitution). RESULTS: Subjects who were homozygous for proline at codon 10 had significantly higher overgrowth scores than those who were heterozygous (P= 0.03) or homozygous for leucine (P= 0.01). Subjects who were heterozygous (arginine/proline) at codon 25 had a significantly higher (P= 0.04) gingival overgrowth score than those who were homozygous for arginine. Logistic regression analysis indicated that for codon 25 independent predictors of severe gingival overgrowth were the heterozygous arginine/proline genotype (P= 0.009) and whether the individual was young (P= 0.05). CONCLUSIONS: Polymorphisms in the TGF-beta1 gene influence the expression of gingival overgrowth in renal transplant recipients concomitantly treated with cyclosporin and a calcium channel blocker. The polymorphism in the TGF-beta1 gene at codon 25 represented an independent genetic determinant of severe gingival overgrowth in the susceptible subjects studied.
Assuntos
Bloqueadores dos Canais de Cálcio/efeitos adversos , Ciclosporina/efeitos adversos , Crescimento Excessivo da Gengiva/classificação , Imunossupressores/efeitos adversos , Transplante de Rim , Polimorfismo Genético/genética , Fator de Crescimento Transformador beta/genética , Adulto , Fatores Etários , Alelos , Análise de Variância , Arginina/genética , Distribuição de Qui-Quadrado , Códon/genética , Intervalos de Confiança , DNA/genética , Feminino , Regulação da Expressão Gênica , Genótipo , Crescimento Excessivo da Gengiva/induzido quimicamente , Crescimento Excessivo da Gengiva/genética , Heterozigoto , Homozigoto , Humanos , Leucina/genética , Modelos Logísticos , Masculino , Razão de Chances , Prolina/genética , Fator de Crescimento Transformador beta1RESUMO
This study describes the formulation, characterisation and preliminary clinical evaluation of mucoadhesive, semi-solid formulations containing hydroxyethylcellulose (HEC, 1-5%, w/w), polyvinylpyrrolidine (PVP, 2 or 3%, w/w), polycarbophil (PC, 1 or 3%, w/w) and tetracycline (5%, w/w, as the hydrochloride). Each formulation was characterised in terms of drug release, hardness, compressibility, adhesiveness (using a texture analyser in texture profile analysis mode), syringeability (using a texture analyser in compression mode) and adhesion to a mucin disc (measured as a detachment force using the texture analyser in tensile mode). The release exponent for the formulations ranged from 0.78+/-0.02 to 1. 27+/-0.07, indicating that drug release was non-diffusion controlled. Increasing the concentrations of each polymeric component significantly increased the time required for 10 and 30% release of the original mass of tetracycline, due to both increased viscosity and, additionally, the unique swelling properties of the formulations. Increasing concentrations of each polymeric component also increased the hardness, compressibility, adhesiveness, syringeability and mucoadhesion of the formulations. The effects on product hardness, compressibility and syringeability may be due to increased product viscosity and, hence, increased resistance to compression. Similarly, the effects of these polymers on adhesiveness/mucoadhesion highlight their mucoadhesive nature and, importantly, the effects of polymer state (particularly PC) on these properties. Thus, in formulations where the neutralisation of PC was maximally suppressed, adhesiveness and mucoadhesion were also maximal. Interestingly, statistical interactions were primarily observed between the effects of HEC and PC on drug release, mechanical and mucoadhesive properties. These were explained by the effects of HEC on the physical state of PC, namely swollen or unswollen. In the preliminary clinical evaluation, a formulation was selected that offered an appropriate balance of the above physical properties and contained 3% HEC, 3% PVP and 1% PC, in addition to tetracycline 5% (as the hydrochloride). The clinical efficacy of this (test) formulation was compared to an identical tetracycline-devoid (control) formulation in nine periodontal pockets (>/=5 mm depth). One week following administration of the test formulation, there was a significant improvement in periodontal health as identified by reduced numbers of sub-gingival microbial pathogens. Therefore, it can be concluded that, when used in combination with mechanical plaque removal, the tetracycline-containing semi-solid systems described in this study would augment such therapy by enhancing the removal of pathogens, thus improving periodontal health.
Assuntos
Antibacterianos/administração & dosagem , Antibacterianos/uso terapêutico , Doenças Periodontais/tratamento farmacológico , Tetraciclina/administração & dosagem , Tetraciclina/uso terapêutico , Resinas Acrílicas , Algoritmos , Celulose/análogos & derivados , Química Farmacêutica , Portadores de Fármacos , Excipientes , Géis , Humanos , Mucosa Bucal/efeitos dos fármacos , Doenças Periodontais/microbiologia , Povidona , Seringas , Adesivos TeciduaisRESUMO
BACKGROUND/AIMS: To investigate whether the choice of calcium channel blocker, used in conjunction with cyclosporin A, affected the prevalence of gingival overgrowth. METHOD: A cohort of 135 renal transplant recipients who had been medicated with cyclosporin A in combination with either nifedipine (89) or amlodipine (46) since transplant, took part in the study. The inclusion criteria were that eligible subjects had been in receipt of a kidney transplant for at least 12 months, had at least 10 teeth and had not received specialist periodontal treatment. The age, gender, current drug regimen and dosage were recorded for each participant and alginate impressions taken of both arches. The presence and severity of gingival overgrowth were scored from plaster models. RESULTS: A higher proportion (72%) of the amlodipine group were categorised as having gingival overgrowth compared with only 53% of the nifedipine group, chi square=4.5, p<0.05. Logistic regression analysis was used to explore the relationship between the presence or absence of gingival overgrowth (dependent variable) and age, gender, time since transplant, dose of cyclosporin A, centre in which the patient was treated, and the calcium channel blocker used (independent variables). Independent predictors of gingival overgrowth in this multivariate analysis were whether the individual was treated with amlodipine or nifedipine (p=0.01) and whether the individual was young or old (p=0.01). Within the multivariate analysis, the odds ratio for amlodipine to be associated with gingival overgrowth compared with nifedipine was 3.0 (confidence interval 1.3-6.9). CONCLUSIONS: The prevalence of gingival overgrowth in renal transplant recipients maintained on cyclosporin A and nifedipine is lower than those treated with cyclosporin A and amlodipine.
Assuntos
Anlodipino/efeitos adversos , Bloqueadores dos Canais de Cálcio/efeitos adversos , Ciclosporina/efeitos adversos , Crescimento Excessivo da Gengiva/induzido quimicamente , Imunossupressores/efeitos adversos , Nifedipino/efeitos adversos , Adulto , Anlodipino/administração & dosagem , Bloqueadores dos Canais de Cálcio/administração & dosagem , Ciclosporina/administração & dosagem , Quimioterapia Combinada , Feminino , Crescimento Excessivo da Gengiva/epidemiologia , Humanos , Imunossupressores/administração & dosagem , Transplante de Rim/estatística & dados numéricos , Masculino , Análise Multivariada , Nifedipino/administração & dosagem , Prevalência , PrognósticoRESUMO
BACKGROUND: Unsightly gingival overgrowth affects many individuals immunosuppressed with cyclosporin A (CsA). Current management involves repeated periodontal surgery and intensive hygienist support. Tacrolimus is an effective alternative immunosuppressive agent for renal transplantation which does not appear to produce gingival enlargement. AIMS: The purpose of the present study was to monitor the gingival response of 4 renal transplant patients (RTPs), with clinically significant CsA-induced gingival overgrowth, after their immunosuppressive therapy was switched to tacrolimus. METHODS: Intra-oral photographs and alginate impressions were taken both prior to the drug conversion and again, 6 to 9 months later. Gingival overgrowth scores were determined, from plaster models on both these occasions. RESULTS: All of the RTPs experienced significant resolution of their gingival enlargement within the time period studied; however, only one had complete regression. CONCLUSION: It is concluded that conversion of RTPs with gingival overgrowth from CsA to tacrolimus may provide an effective management strategy for this clinical problem.
Assuntos
Ciclosporina/efeitos adversos , Crescimento Excessivo da Gengiva/prevenção & controle , Imunossupressores/efeitos adversos , Tacrolimo/uso terapêutico , Adolescente , Adulto , Quimioterapia Combinada , Feminino , Crescimento Excessivo da Gengiva/induzido quimicamente , Crescimento Excessivo da Gengiva/diagnóstico , Humanos , Imunossupressores/uso terapêutico , Transplante de Rim , Masculino , Pessoa de Meia-Idade , Indução de Remissão , Fatores de TempoRESUMO
Differential display is a powerful technique which can be used to identify those genes whose expression is altered between two or more tissues under investigation. We have applied differential display to a rat model of cyclosporin A-induced gingival overgrowth (CIGO) to identify genes which are differentially expressed as a result of drug treatment. Ten weanling Wistar rats were fed with a pelleted diet containing cyclosporin A (CsA) at 120 mg/kg for 10 d and then 200 mg/kg for a further 30 d prior to culling. Experimental rats were compared with 10 age/sex-matched rats on a control diet. Significant evidence of overgrowth was observed in the interdental papilla between the mandibular first and second molar teeth in the CsA group. Differential display was performed on total cellular RNA extracted from the mandibular buccal gingiva. A cDNA product was isolated which was underexpressed in the overgrowth tissue and demonstrated a 95% sequence homology to the human signal recognition particle receptor (Human Docking Protein). Preliminary studies indicate that this gene is also underexpressed in human CIGO tissue. The method of approach and the potential implications of our findings are discussed.
Assuntos
Ciclosporina/efeitos adversos , Regulação para Baixo , Crescimento Excessivo da Gengiva/induzido quimicamente , Imunossupressores/efeitos adversos , Receptores Citoplasmáticos e Nucleares/genética , Receptores de Peptídeos/genética , Partícula de Reconhecimento de Sinal/genética , Animais , Estudos de Casos e Controles , Modelos Animais de Doenças , Gengiva/metabolismo , Crescimento Excessivo da Gengiva/genética , Humanos , Masculino , RNA/genética , Ratos , Ratos Wistar , Análise de Sequência de RNA , Homologia de Sequência do Ácido NucleicoRESUMO
In this study, the physicochemical properties and preliminary in vivo clinical performance of formulations containing hydroxyethylcellulose (HEC; 3, 5, 10% w/w), poly(vinylpyrrolidone) (PVP; 3, 5% w/w), polycarbophil (PC; 1, 3, 5% w/w), and flurbiprofen (5% w/w) were examined. Flurbiprofen release into PBS pH 7.4 was performed at 37 degrees C. The mechanical properties (hardness, compressibility, adhesiveness, initial stress) and syringeability of formulations were determined using a texture analyzer in texture profile analysis (TPA) and compression modes, respectively. In general, the time required for release of 10 and 30% of the original mass of flurbiprofen (t10%, t30%) increased as the concentration of each polymeric component increased. However, in the presence of either 5 or 10% HEC and 5% PC, increased PVP concentration decreased both t10%, t30% due to excessive swelling (and disintegration) of these formulations. Increased concentrations of HEC, PVP, and PC significantly increased formulation hardness, compressibility, work of syringe expression, and initial stress due to the effects of these polymers on formulation viscoelasticity. Similarly, increased concentrations of PC (primarily), HEC, and PVP increased formulation adhesiveness due to the known bioadhesive properties of these polymers. Clinical efficacies of formulations containing 3% HEC, 3% PVP, 3% PC, and either 0% (control) or 5% (test) flurbiprofen, selected to offer optimal drug release and mechanical properties, were evaluated and clinically compared in an experimental gingivitis model. The test (flurbiprofen-containing) formulation significantly reduced gingival inflammation, as evaluated using the gingival index, and the gingival crevicular fluid volume, whereas, these clinical parameters were generally increased in volunteers who had received the control formulation. There were no observed differences in the plaque indices of the two subject groups, confirming that the observed differences in gingival inflammation could not be accredited to differences in plaque accumulation. This study has shown both the applicability of the in vitro methods used, particularly TPA, for the rational selection of formulations for clinical evaluation and, additionally, the clinical benefits of the topical application of a bioadhesive semisolid flurbiprofen-containing formulation for the treatment of experimental gingivitis.
Assuntos
Resinas Acrílicas/administração & dosagem , Resinas Acrílicas/química , Anti-Inflamatórios não Esteroides/administração & dosagem , Anti-Inflamatórios não Esteroides/química , Celulose/análogos & derivados , Flurbiprofeno/administração & dosagem , Flurbiprofeno/química , Gengivite/tratamento farmacológico , Excipientes Farmacêuticos/administração & dosagem , Excipientes Farmacêuticos/química , Povidona/administração & dosagem , Povidona/química , Adesividade , Celulose/administração & dosagem , Celulose/química , Força Compressiva , Preparações de Ação Retardada , Método Duplo-Cego , Portadores de Fármacos , Géis/administração & dosagem , Géis/química , Dureza , HumanosRESUMO
BACKGROUND: Gingival overgrowth is a common side effect following the administration of cyclosporin A (CsA); however, the cellular mechanisms remain poorly understood. CsA's immunosuppressant properties involve the regulation of synthesis and cellular response to cytokines. A CsA-induced alteration in the cytokine profile within gingival tissue could provide a mechanism for gingival hyperplasia. The aim of this study was to investigate the effects of CsA on the production of 2 cytokines - interleukin-1beta (IL-1beta) and interleukin-6 (IL-6) - by both gingival fibroblasts and peripheral blood mononuclear cells (PBMC). METHODS: Cells were stimulated for 24 hours in the presence of CsA over a concentration range of 100 to 2,000 ng/ml and the resultant cytokine production determined by ELISA. In addition, levels of both cytokines within normal, inflamed, and overgrown gingival tissue were determined. RESULTS: CsA inhibited IL-6 production by gingival fibroblasts in a dose-dependent manner. In contrast, at a concentration of 2,000 ng/ml, CsA stimulated IL-6 production by PBMC (P <0.05). Fibroblasts derived from overgrown gingiva produced significantly higher levels of IL-6 than their normal counterparts (P <0.05). CsA inhibited IL-1beta production by PBMC over the whole concentration range (P <0.05). IL-1beta was not found in measurable quantities in any of the fibroblast cultures. Levels of IL-6 extracted from overgrown gingival tissue were significantly higher than in inflamed or normal tissue. In contrast IL-1beta levels in overgrown tissue were not statistically significantly greater than those in inflamed tissue. CONCLUSIONS: These results show that CsA does regulate cytokine expression in gingival tissue. This effect may play an important role in the pathogenesis of CsA-induced gingival overgrowth.
Assuntos
Ciclosporina/farmacologia , Gengiva/efeitos dos fármacos , Crescimento Excessivo da Gengiva/induzido quimicamente , Imunossupressores/farmacologia , Interleucina-1/metabolismo , Interleucina-6/metabolismo , Adulto , Células Cultivadas , Ciclosporina/administração & dosagem , Relação Dose-Resposta a Droga , Ensaio de Imunoadsorção Enzimática , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Gengiva/citologia , Gengiva/metabolismo , Hiperplasia Gengival/induzido quimicamente , Hiperplasia Gengival/metabolismo , Crescimento Excessivo da Gengiva/metabolismo , Gengivite/metabolismo , Gengivite/patologia , Humanos , Imunossupressores/administração & dosagem , Interleucina-1/genética , Interleucina-6/genética , Leucócitos Mononucleares/efeitos dos fármacos , Leucócitos Mononucleares/metabolismo , MasculinoRESUMO
OBJECTIVES: To investigate the prevalence and severity of gingival overgrowth in a group of renal transplant recipients treated in one centre in Northern Ireland. STUDY DESIGN: A consecutive group of patients who had had a renal transplant for at least 6 months and were attending the Renal Unit in Belfast City Hospital took part in the study. These were divided into a group of 84 subjects treated with cyclosporin since their transplant who were compared with a control group of 36 transplant recipients who had never received cyclosporin. Each subject had a periodontal examination and completed a questionnaire. The severity of gingival overgrowth was scored from plaster models. OUTCOME MEASURES: Clinically significant gingival overgrowth was equated with a score of > or = 30 using the index developed by Seymour et al (1985). RESULTS: 41 (49%) of the cyclosporin group had clinically significant gingival overgrowth compared with none of the controls. A significantly higher proportion of males had overgrowth than females. There were significant correlations between age at transplant, plaque, bleeding, pocketing and the severity of gingival overgrowth. Many patients with clinically significant gingival overgrowth were apparently unconcerned about this condition. CONCLUSIONS: It is concluded that gingival overgrowth is a significant problem for renal transplant patients treated with cyclosporin, particularly if they are also treated with a calcium channel blocker. None of the factors measured, in isolation, explained the variable expression of gingival overgrowth in those at risk.
Assuntos
Ciclosporina/efeitos adversos , Assistência Odontológica para Doentes Crônicos , Crescimento Excessivo da Gengiva/etiologia , Transplante de Rim , Adulto , Fatores Etários , Placa Dentária/complicações , Índice de Placa Dentária , Feminino , Humanos , Masculino , Índice PeriodontalRESUMO
Fibroblasts incorporated within collagen gels induce a cell-mediated contraction of the gel to form a three-dimensional, tissue-like structure by a mechanism thought to mimic wound contraction in vivo. In this study a gel contraction model was used to investigate the ability of fibroblasts derived from adult gingiva, adult skin and fetal skin to organise a collagen matrix. In addition the effects of interleukin-1beta (IL-1beta) on the contraction process was also investigated. Over the concentration range 5-50 U/ml, IL-1beta induced a statistically significant inhibition of gel contraction in all fibroblast cell types (P<0.05), although fetal fibroblasts appeared least responsive and gingival fibroblasts most responsive to the inhibitory effects of this cytokine. Comparison of gel contraction by the different fibroblast strains indicated that fetal and gingival fibroblasts shared similar contraction kinetics. For the adult skin fibroblasts, three of five strains studied showed significantly diminished levels of gel contraction compared to fetal and gingival cells. This apparent difference in fibroblast phenotype may, at least in part, explain the fetal-like wound healing pattern seen in the oral mucosa.